APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

APLS is currently covered by 15 analysts with an average potential upside of $17.11 (42.39%) backed by displayed 93 price targets and 145 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.6% with an average time for these price targets to be met of 244.17 days.

Highest price target for APLS is 93, Lowest price target is 24, average price target is 58.5.

Most recent stock forecast was given by MADHU KUMAR from GOLDMAN on 09-Nov-2023. First documented stock forecast 04-Dec-2017.

Currently, out of the existing stock ratings of APLS - 57 which are a Buy (79.17%), 15 which are a Hold (20.83%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

74

$23.7 (47.12%)

91

22 days ago

5/6 (83.33%)

$17.78 (52.25%)

373

Buy

93

$42.7 (84.89%)

29 days ago

0/7 (0%)

$52.79 (84.80%)

Buy

63

$12.7 (25.25%)

60

1 months ago

4/7 (57.14%)

$21.72 (48.53%)

436

Hold

46

$-4.3 (-8.55%)

43

1 months 19 days ago

5/5 (100%)

$11.73 (30.03%)

63

Buy

70

$19.7 (39.17%)

54

1 months 25 days ago

17/19 (89.47%)

$23.35 (61.50%)

240

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 244.17 days on average for the stock forecasts to be realized with a an average price target met ratio 80.6

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

CHRIS HOWERTON

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Chris Howerton works at JEFFERIES and has 3 price targets and 4 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Douglas Tsao with highest potential upside - $43.96

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Laura Chico with lowest potential downside - -$21.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart